ESR1 is a key protein in the cancer pathway, which is closely associated with the adhesion and migration of tumor cells, and the suppression of EAR1 expression can inhibit the estrogen receptor (ER) breast cancer cells. This evidence concerns the gene NR1D1 and breast carcinoma.